Candel Therapeutics Inc
NASDAQ:CADL
Intrinsic Value
The intrinsic value of one
CADL
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 5.59 USD,
Candel Therapeutics Inc
is
hidden
.
Valuation History
Candel Therapeutics Inc
CADL looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether CADL usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Candel Therapeutics Inc.
Fundamental Analysis
CADL Profitability Score
Profitability Due Diligence
Score
CADL Solvency Score
Solvency Due Diligence
Score
Balance Sheet Decomposition
Candel Therapeutics Inc
Candel Therapeutics Inc
Free Cash Flow Analysis
Candel Therapeutics Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Candel Therapeutics Inc
Wall St
Price Targets
CADL Price Targets Summary
Candel Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
CADL
is 19 USD
with a low forecast of 7.07 USD and a high forecast of 26.25 USD.
Dividends
Current shareholder yield for
CADL is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CADL
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 5.59 USD,
Candel Therapeutics Inc
is
hidden
.